JPRN-UMIN000004444招募中未知
Tumor imaging using 68Ga-octreotide - Somatostatin receptor scintigaraphy
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Communication disturbance 2. Extremely poor physical status 3. Informed consent not available
研究者
相似试验
尚未招募
2 期
Role of somatostatin receptor imaging in patients with metastatic breast cancerCTRI/2023/03/051025All India Institute of Medical Sciences, New Delhi
终止
早期 1 期
68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine TumorsMetastatic Well Differentiated Neuroendocrine NeoplasmSomatostatin Positive Neoplastic Cells PresentNeuroendocrine NeoplasmVon Hippel-Lindau SyndromeMeningiomaMultiple Endocrine Neoplasia Type 1NCT03001349M.D. Anderson Cancer Center4
进行中（未招募）
1 期
Octreotide PET/CT scan for the imaging of disease activity in neurologic and cardiac sarcoidosis.Sarcoidosis.EUCTR2016-002160-14-NLSt. Antonius Hospital
已完成
不适用
68Ga-DOTA-NOC PET/CT for the imaging of disease activity in neurologic and cardiac sarcoidosis.NL-OMON42936Sint Antonius Ziekenhuis40
已完成
2 期
Imaging Malignant Glioma With 68Ga-DOTATOC PET/CTGliomaNCT01460706Turku University Hospital30